OC10: THE FETAL BRAIN EXPOSED TO ZIKA AND CMV VIRUS

Objectives:
The main objectives of this study were to describe the ultrasound semiology encountered in congenital Zika virus syndrome (CZVS), and to establish a score to predict the neonatal and infantile prognosis.
Methods: This prospective cohort study was conducted during 2016, in western French Guiana and included 301 women who contracted ZKV during pregnancy and 399 controls. The patients were followed by monthly ultrasound examinations. Using data from the literature, we developed an analysis grid for cerebral and neurological abnormalities that may be attributable to ZKV. Cases of severe CNS anomalies were scored independently by two sonographers according to this grid, and the mean was reported. Results: Severe neurological abnormalities were found in 15 fetuses: 4 CZVS confirmed by positive fetal samples, 8 CVZS suspected due to maternal seroconversion and 3 cases in controls.
All fetuses with virological evidence of ZKV infection had a total score higher than 15 (median 19). Fetuses without virological evidence of ZKV infection had a lower score, below 10 (median 5). Fetuses from the control group also had a score below 10 (median 8).
Thin cortical mantle, calcifications, reduced biometrics, ventriculomegaly and posterior fossa disorders were frequently found in confirmed CVZS.
The semiology of uncertain cases was different; the cerebral mantle structure did not seem to have been altered, and the calcifications were often absent.
Conclusions:
The ultrasound semiology analysis according to the proposed score indicates that it can be useful in the identification of CZVS particularly in non-endemic areas. When the score is low it is not expected to found serological evidence of recent ZKV infection. Conversely, a score higher than 15 seems to be a good predictor of severe CZVS with viral replication still active. 5%) ; posterior fossa anomalies 6/84 (7.1%); and arthrogryposis 1/84 (1.1%). Additionally, 11/88 (12.5%) of studied fetuses had non-CNS anomalies (54% congenital heart anomalies). Intrauterine growth restriction (<p 10 ) was observed in 6/88 (6.8%) of the cohort. Conclusions: We found a significantly higher rate of CNS anomalies in this prospective cohort of Zika symptomatic mothers than previously published in the literature. This may be explained by the level of expertise performing the ultrasounds and/or the standardised transvaginal technique used. The most common anomalies observed were: alterations in corpus callosum, microcephaly, and calcifications. Methods: Within our cohort of CCMV confirmed by positive amniotic fluid PCR, we excluded cases of severe encephalic anomalies diagnosed by ultrasound during mid-trimester follow-up. A MRI was systematically performed at 30-34 weeks in the remaining cases. White matter hyperintense T2 signal (WMHS) was defined as a signal ratio of temporal areas over basa ganglia and was considered abnormal when >1.4. Adverse pediatric outcomes included bilateral neurosensory hearing loss (NSHL) and neurological impairment. Over the last 5 years, fetal therapy by valacyclovir was systematically offered in moderately symptomatic fetuses. Results: An MRI was performed in 57 cases with a reassuring mid-trimester assessment, as part of final prognostic assessment: 33 cases were asymptomatic; 20 presented extracranial moderate symptoms such as hyperechoic bowel, IUGR, hepatosplenomegaly; 4 presented moderate intracranial anomalies such as posterior intraventricular adhesion or leucostriate vasculopathy. MRI confirmed ultrasound findings (normal or moderate anomalies) in all but one case. However, WMHS was found in 6/33 (18%) asymptomatic cases and was significantly associated with NSHL (3/6 vs. 0/27, P=0.004). In fetuses with extracranial anomalies, WMHS was found in 7/20 (35%) and was also associated with an adverse outcome (3/7 vs. 1/20, P=0.04). 3/4 fetuses with moderate intracranial anomalies prior to MRI showed WMHS, one of which suffered severe neurological impairment. Conclusions: WMHS is independently associated with an adverse outcome following a reassuring mid-trimester assessment for CCMV. In asymptomatic fetuses, such a finding would suggest a 50% risk of NSHL, whereas its absence strongly suggests a favourable outcome. Patients were referred to our unit due to seroconversion at the first or second trimester with or without suspected sonographic finding and turned out to be either positive for CMV by amniocentesis or in urine neonatal samples.
OC10.02 Prevalent and incident cases of CNS anomalies in fetuses of
The patients underwent repeated ultrasonographic and neurosongraphic examinations in the search of findings related to CMV infection. Patients with a positive ultrasonographic finding were examined by two different senior physicians and underwent MRI evaluation.
Follow up of the delivered children was obtained from patient's files and from parents' interviews. All the children underwent neurological evaluation and BERA examinations. Results: We have found 21 fetuses with caudate nuclei, in seven the finding was isolated. Fourteen fetuses were with associated findings such as periventricular hyper echogenicity, LSV, periventricular or cerebral cysts and calcifications. These 14 patients elected to terminate the pregnancy.
The seven children with the isolated echogenic caudate had a negative BERA and normal neurological evaluation with a follow-up to the age of three. Conclusions: Our results indicate that the presence of an echogenic caudate in CMV infected fetuses is relatively common and seems to be associated with a good neurological outcome. 
